Frazer I H, Mackay I R
Clin Exp Immunol. 1982 Oct;50(1):107-14.
Lymphocyte subpopulations were enumerated in human peripheral blood using murine monoclonal antibodies with specificity for all peripheral blood T lymphocytes (OKT3, alpha-Leu 1) and for the helper subset (OKT4, alpha Leu 3a) and suppressor/cytotoxic subset (OKT8, alpha Leu 2a). Patients with chronic active hepatitis (CAH) (23) or systemic lupus erythematosus (SLE) (10), compared with healthy subjects (20), had a lower mean T lymphocyte count. Patients with CAH had normal numbers of suppressor/cytotoxic (TSC) cells, but fewer helper (TH) cells than healthy subjects (0 . 96 +/- 0 . 11 X 10(9)/1 versus 1 . 45 +/- 0 . 15 X 10(9)/1), and those with SLE also had fewer TH cells (0 . 93 +/- 0 . 11 X 10(9)/1). Patients with CAH receiving azathioprine (n = 8) had significantly fewer TSC cells, and a higher TH/TSC ratio (2 . 69 +/- 0 . 35) than those (n = 15) not on this therapy (1 . 85 +/- 0 . 15). When patients taking azathioprine were excluded, no correlation was found between disease activity and the TH/TSC ratio for either disease.
使用对所有外周血T淋巴细胞(OKT3、α-Leu 1)、辅助亚群(OKT4、α Leu 3a)和抑制/细胞毒性亚群(OKT8、α Leu 2a)具有特异性的鼠单克隆抗体,对人外周血中的淋巴细胞亚群进行计数。与健康受试者(20例)相比,慢性活动性肝炎(CAH)患者(23例)或系统性红斑狼疮(SLE)患者(10例)的平均T淋巴细胞计数较低。CAH患者的抑制/细胞毒性(TSC)细胞数量正常,但辅助(TH)细胞数量比健康受试者少(0.96±0.11×10⁹/1对1.45±0.15×10⁹/1),SLE患者的TH细胞也较少(0.93±0.11×10⁹/1)。接受硫唑嘌呤治疗的CAH患者(n = 8)的TSC细胞明显较少,TH/TSC比值(2.69±0.35)高于未接受该治疗的患者(n = 15)(1.85±0.15)。当排除服用硫唑嘌呤的患者后,两种疾病的疾病活动度与TH/TSC比值之间均未发现相关性。